These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24565004)

  • 21. Therapeutic Potential of Targeting the Ghrelin Pathway.
    Colldén G; Tschöp MH; Müller TD
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ghrelin response to hedonic eating in underweight and short-term weight restored patients with anorexia nervosa.
    Maria Monteleone A; Monteleone P; Dalle Grave R; Nigro M; El Ghoch M; Calugi S; Cimino M; Maj M
    Psychiatry Res; 2016 Jan; 235():55-60. PubMed ID: 26674388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastric function in eating disorders.
    Robinson PH
    Ann N Y Acad Sci; 1989; 575():456-64; discussion 464-5. PubMed ID: 2699203
    [No Abstract]   [Full Text] [Related]  

  • 24. A systematic review of the effects of neuromodulation on eating and body weight: evidence from human and animal studies.
    McClelland J; Bozhilova N; Campbell I; Schmidt U
    Eur Eat Disord Rev; 2013 Nov; 21(6):436-55. PubMed ID: 24155246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Translational research on the clinical applications of ghrelin.
    Akamizu T; Kangawa K
    Endocr J; 2006 Oct; 53(5):585-91. PubMed ID: 16873986
    [No Abstract]   [Full Text] [Related]  

  • 26. The opioids, dopamine, cholecystokinin, and eating disorders.
    Gillman MA; Lichtigfeld FJ
    Clin Neuropharmacol; 1986; 9(1):91-7. PubMed ID: 3548955
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comorbidity of eating disorders and bipolar affective disorders].
    Kamińska K; Rybakowski F
    Psychiatr Pol; 2006; 40(3):455-67. PubMed ID: 17037812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of ghrelin, salivary secretions, and dental care in eating disorders.
    Yagi T; Ueda H; Amitani H; Asakawa A; Miyawaki S; Inui A
    Nutrients; 2012 Aug; 4(8):967-89. PubMed ID: 23016127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sleep architecture in eating disorders.
    Walsh BT; Goetz R
    Arch Gen Psychiatry; 1990 Sep; 47(9):880. PubMed ID: 2393350
    [No Abstract]   [Full Text] [Related]  

  • 30. Obesity: Current and potential pharmacotherapeutics and targets.
    Narayanaswami V; Dwoskin LP
    Pharmacol Ther; 2017 Feb; 170():116-147. PubMed ID: 27773782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating ghrelin is decreased in non-obese and obese women with binge eating disorder as well as in obese non-binge eating women, but not in patients with bulimia nervosa.
    Monteleone P; Fabrazzo M; Tortorella A; Martiadis V; Serritella C; Maj M
    Psychoneuroendocrinology; 2005 Apr; 30(3):243-50. PubMed ID: 15511598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leptin, ghrelin, and endocannabinoids: potential therapeutic targets in anorexia nervosa.
    Støving RK; Andries A; Brixen K; Flyvbjerg A; Hørder K; Frystyk J
    J Psychiatr Res; 2009 Apr; 43(7):671-9. PubMed ID: 18926548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using real-time fMRI brain-computer interfacing to treat eating disorders.
    Sokunbi MO
    J Neurol Sci; 2018 May; 388():109-114. PubMed ID: 29627003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma ghrelin in anorexia, bulimia, and binge-eating disorder: relations with eating patterns and circulating concentrations of cortisol and thyroid hormones.
    Troisi A; Di Lorenzo G; Lega I; Tesauro M; Bertoli A; Leo R; Iantorno M; Pecchioli C; Rizza S; Turriziani M; Lauro R; Siracusano A
    Neuroendocrinology; 2005; 81(4):259-66. PubMed ID: 16131812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of pharmacotherapy in anorexia nervosa and bulimia.
    Tolstoi LG
    J Am Diet Assoc; 1989 Nov; 89(11):1640-6. PubMed ID: 2572619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eating disorders.
    Wiseman CV; Harris WA; Halmi KA
    Med Clin North Am; 1998 Jan; 82(1):145-59. PubMed ID: 9457155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Serotonin and eating disorders].
    Nutzinger DO; de Zwaan M; Schönbeck G
    Nervenarzt; 1991 Mar; 62(3):198-201. PubMed ID: 2052121
    [No Abstract]   [Full Text] [Related]  

  • 38. Obesity, eating disorders and restrained eating: is leptin the missing link?
    Mantzoros CS
    Mol Psychiatry; 1997 Sep; 2(5):377-80. PubMed ID: 9322227
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical, psychopathological and personality correlates of interoceptive awareness in anorexia nervosa, bulimia nervosa and obesity.
    Fassino S; Pierò A; Gramaglia C; Abbate-Daga G
    Psychopathology; 2004; 37(4):168-74. PubMed ID: 15237246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A ghrelin gene variant may predict crossover rate from restricting-type anorexia nervosa to other phenotypes of eating disorders: a retrospective survival analysis.
    Ando T; Komaki G; Nishimura H; Naruo T; Okabe K; Kawai K; Takii M; Oka T; Kodama N; Nakamoto C; Ishikawa T; Suzuki-Hotta M; Minatozaki K; Yamaguchi C; Nishizono-Maher A; Kono M; Kajiwara S; Suematsu H; Tomita Y; Ebana S; Okamoto Y; Nagata K; Nakai Y; Koide M; Kobayashi N; Kurokawa N; Nagata T; Kiriike N; Takenaka Y; Nagamine K; Ookuma K; Murata S;
    Psychiatr Genet; 2010 Aug; 20(4):153-9. PubMed ID: 20421852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.